$3.890
-0.226 (-5.81%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ORMP Prediction & Forecast by Similar Chart Analysis
Alphio's ORMP stock price prediction model matches the current Oramed Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.90 (+0.38%). The 1-week path is $3.90 (+0.16%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Oramed Pharmaceuticals Inc Stock?
Oramed Pharmaceuticals Inc is currently trading at $4, which is 56.5% of its 52-week range, indicating it is closer to its 52-week high of $5.47. However, the RSI is at a low 29.89, suggesting the stock is oversold. The company reported a profit of $10 million in Q4, translating to an EPS of $0.24, which reflects strong profitability despite low revenue. The main risk is the significant drop in revenue with total revenue reported as $2 million in Q1 2025 and a projected earnings surprise of -120.93% in the last earnings report, indicating potential volatility ahead.
ORMP stock price ended at $3.89 on Thursday, after losing -5.81%
Oramed Pharmaceuticals Inc (ORMP) last closed at $3.8900001, losing -5.81%. These facts feed the 1-day and 1-week ORMP price prediction above.
Analyst Consensus
Oramed Pharmaceuticals Inc (ORMP): 2 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Oramed Pharmaceuticals Inc (ORMP) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ORMP, ranked by similarity.
Seasonality analysis for ORMP
Historically the probability of a positive November return for ORMP is 32.56%. December offers the highest probability of a positive month at 74.42%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ORMP
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.92 | $2.16 | $2.28 | -44.39% |
| Dec 2026 | $2.47 | $2.51 | $2.54 | -35.53% |
In 2026, Oramed Pharmaceuticals Inc (ORMP) is projected to range from $1.92 to $2.54.
Oramed Pharmaceuticals Inc 2026 monthly forecast
In Nov 2026, Oramed Pharmaceuticals Inc is projected to average $2.16, with a low of $1.92 and high of $2.28.
In Dec 2026, Oramed Pharmaceuticals Inc is projected to average $2.51, with a low of $2.47 and high of $2.54.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.